Recently, we have found that the activation of FGFR2 induces TNBC with multiple signaling, such as cancer stem cells (CSCs), epithelial–mesenchymal transition (EMT), and the tumor microenvironment (TME) (19). Here, FGFR2 is linked to cancer.